By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Adocia 

115 avenue Lacassagne

Lyon    69003  France
Phone: +33-(0)4-72-610-610 Fax: +33-(0)4-72-363-967


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





Company News
Adocia And Eli Lilly (LLY) Announce Positive Topline Results From A Phase 1b Study Of Repeated Administration Of Ultra-Rapid Biochaperone Lispro U100 In People With Type 2 Diabetes 5/2/2016 1:17:18 PM
Adocia Announces First Quarter 2016 Results 4/14/2016 9:26:51 AM
Adocia Initiates A Phase 1/2 Clinical Trial On The Post-Meal Effect Of Rapid-Acting Human Insulin, HinsBet U100 4/12/2016 10:43:25 AM
Adocia Welcomes Internationally Renowned Diabetes Experts To Inaugural Medical Advisory Board 3/22/2016 2:14:42 PM
Adocia Announced Its Financial Results For 2015: 3/17/2016 12:40:33 PM
Adocia And Eli Lilly (LLY) Announce Positive Topline Results From A Phase 1b Study Of Repeated Administration Of Ultra-Rapid Biochaperone Lispro In Patients With Type 1 Diabetes 3/15/2016 8:49:01 AM
Adocia And Eli Lilly (LLY) Initiate Phase 1b Study Evaluating Ultra-Rapid Insulin BioChaperone Lispro U100 In Healthy Japanese Subjects 1/29/2016 8:59:12 AM
Adocia To Hold Conference Call For Investors To Provide 2015 Annual Business Update And Perspectives For 2016 Thursday December 17, 2015 at 5:45 PM (CET) 12/16/2015 11:03:40 AM
Adocia And Eli Lilly (LLY) Report Positive Results Of A Pilot Bioequivalence Study Comparing Biochaperone Lispro U200 To Biochaperone Lispro U100 12/11/2015 9:38:04 AM
Adocia Announces Positive Phase 1b Results Of BioChaperone Combo In Patients With Type 2 Diabetes 11/25/2015 1:09:12 PM
123456
//-->